Bristol-Myers Squibb PFD... (BMYMP)
PNK: BMYMP
· Real-Time Price · USD
831.56
26.56 (3.30%)
At close: Apr 25, 2025, 1:34 PM
3.30% (1D)
| Bid | 778.55 |
| Market Cap | 102.16B |
| Revenue (ttm) | 47.64B |
| Net Income (ttm) | 5.42B |
| EPS (ttm) | 0.225 |
| PE Ratio (ttm) | 3695.82 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 855.57 |
| Volume | 3 |
| Avg. Volume (20D) | 1 |
| Open | 805.00 |
| Previous Close | 805.00 |
| Day's Range | 801.01 - 831.56 |
| 52-Week Range | 701.00 - 1225.00 |
| Beta | 0.14 |
About BMYMP
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group....
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Dec 8, 2003
Employees NaN
Stock Exchange PNK
Ticker Symbol BMYMP